Skip to main content
Pamela Kunz, MD, Oncology, North Haven, CT

Pamela Lyn Kunz MD

Oncology•North Haven, CT

Gastrointestinal Cancer

Professor, Medicine - Oncology, Yale Cancer Center

Join to view full profile

  • Smilow Cancer Hospital - Yale North Haven6 Devine StreetNorth Haven, CT 06473

  • Phone+1 203-200-4422

  • Fax+1 203-200-6950

Dr. Kunz is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Kunz's full profileAlready have an account?

Summary

  • Dr. Pamela Kunz, MD, is an Oncology specialist focusing on Gastrointestinal Cancer, with significant experience in neuroendocrine tumors and gastrointestinal oncology. She is currently based at Yale Cancer Center in New Haven, CT. Dr. Kunz completed her residency and fellowship at Stanford University, after earning her medical degree at Geisel School of Medicine at Dartmouth. She served as an Assistant Professor at Stanford Health Care from 2009-2020 and is now a Professor at Smilow Cancer Hospital. She has multiple publications, with some cited work in high impact journals, also being involved in multiple clinical trials.

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2006 - 2008
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityChief Residency, Internal Medicine, 2004 - 2005
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2001 - 2004
  • Geisel School of Medicine at Dartmouth
    Geisel School of Medicine at DartmouthClass of 2001

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2020 - 2027
  • NY State Medical License
    NY State Medical License 2024 - 2027
  • CA State Medical License
    CA State Medical License 2002 - 2026
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Resear... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • Structured Exercise Improves Survival in Patients with Stage II/III Colon Cancer
    Structured Exercise Improves Survival in Patients with Stage II/III Colon CancerJuly 18th, 2025
  • Biomedical Research Saves Human Lives
    Biomedical Research Saves Human LivesJune 30th, 2025
  • ctDNA-MRD Should Be “Standard Component” Of DLBCL Assessment, Data Suggest
    ctDNA-MRD Should Be “Standard Component” Of DLBCL Assessment, Data SuggestJune 3rd, 2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Pamela Kunz, Dr. Pamela Kunz, MD, Dr. P Kunz, Dr. Pamela Lyn Kunz